文献速递治疗药物监测与药物基因组学

GenoStaR:用于主要细胞色素P450基因家族基因型至星等位基因转换的R包

GenoStaR: An R Package for Genotype to Star Allele Conversion for Major Cytochrome P450 Family of Genes.
PubMed 文献 · Clin Pharmacol Ther · 2025-09-05

GenoStaR是一个R包,可将CYP1A2、CYP2B6、CYP2C9、CYP2C19、CYP2D6、CYP3A4和CYP3A5的基因型转换为星等位基因并预测代谢者状态,在IMPACT研究(n=8,287)和多伦多精神分裂症样本(n=188)中二倍型判定一致率均达100%。

要点

  • GenoStaR覆盖7个主要CYP基因,支持SNP、插入缺失和结构变异。
  • 在两个验证数据集(n=8,287和n=188)中二倍型判定一致率均为100%。
  • 可处理CYP2D6拷贝数变异等复杂场景,预测代谢者状态。

核心结论

  • GenoStaR能可靠、高效、准确地将基因型转换为星等位基因并预测CYP相关代谢者状态。

研究设计与样本

  • GenoStaR为R包,使用等位基因定义表判定二倍型、活性评分和预测代谢者状态。
  • 验证数据集一为IMPACT研究(n=8,287),含基因分型数据及商业药物基因组检测的星等位基因信息。
  • 验证数据集二为多伦多精神分裂症样本(n=188),含内部基因分型数据和人工验证的星等位基因。

主要发现

  • GenoStaR在两个验证数据集中二倍型判定一致率均达100%。
  • GenoStaR采用分层匹配策略和结构变异检测,可处理CYP2D6拷贝数变异等复杂场景。

临床怎么用

  • GenoStaR可用于临床药物基因组学检测中CYP基因的基因型至星等位基因转换及代谢者状态预测。
  • GenoStaR在大规模验证数据集上的性能支持其提升临床药物基因组学检测的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacogenomics enables the personalization of drug therapy by linking genetic variations to differences in drug metabolism, efficacy, and risk of adverse reactions. Genetic polymorphisms within cytochrome P450 (CYP) genes significantly affect enzyme activity, influencing drug plasma levels, responses, and safety. Central to this process is accurate genotype-to-phenotype translation, especially for the CYP enzyme family, which metabolizes 70-80% of clinically used drugs. To address this, we have developed GenoStaR, an R package that converts genotypes into star alleles and predicts the associated metabolizer status for major cytochrome P450 genes-CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5. GenoStaR assigns star alleles using single-nucleotide polymorphisms, insertion-deletion variants, and structural variants. Given genotype data, GenoStaR uses comprehensive allele definition tables to determine diplotypes, activity scores, and predicted metabolizer status. The tool accounts for complex scenarios, including CYP2D6 copy number variations, using a tiered matching strategy and structural variant detection. We evaluated GenoStaR using two datasets. The first from the Centre for Addiction and Mental Health Individualized Medicine: Pharmacogenetics Assessment and Clinical Treatment (IMPACT) study (n = 8,287), which included genotyping data, along with star allele information from a commercial pharmacogenetic test. The second, the Toronto Schizophrenia sample (n = 188), with in-house genotype data and manually validated star alleles. GenoStaR achieved 100% concordance in diplotype calls across both datasets. GenoStaR offers a reliable, efficient, and accurate solution for converting genotypes into star alleles and predicting CYP-related metabolizer status. Its performance on a large validation dataset highlights its potential to enhance pharmacogenomic testing in clinical settings.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Coulter AJ, Thamilselvan M, Kennedy JL, et al. GenoStaR: An R Package for Genotype to Star Allele Conversion for Major Cytochrome P450 Family of Genes. Clin Pharmacol Ther. 2025. PMID: 40908856. doi:10.1002/cpt.70059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。